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Acquired valvular heart disease is manifest clinically as 
either valvular stenosis or regurgitation. The following disor- 
ders are considered here in the context of competitive athletes: 
mitral valve stenosis, mitral valve regurgitation, aortic valve 
stenosis, aortic valve regurgitation, tricuspid valve stenosis, 
tricuspid valve regurgitation and multivalvular disease. Like- 
wise, procedures such as valvuloplasty and bioprosthetic and 
prosthetic valve replacement are also discussed. 
Diagnosis of the rype of valvular heart disease usually can be 
made on the basis of physical examination alone owing to the 
characteristic murmurs. Estimation of the scv&y of valvular 
disease is more difficult, but in asymptomatic patients in whom 
the cardiac output is not decreased, severity can usually be 
estimated from the history, physical examination, electrocar- 
diogram (KG), chest radiograph and Doppler echocardiog- 
raphy. Radioisotope volume studies with estimation of ejection 
fraction (with and without exercise) m&y also be useful, 
particularly in regurgitant lesions. 
Doppler echocardiography is reliable in d~stiaguishiog se- 
mild aortic valve stenosis bur may be less so in 
aortic stenosis of borderline severity, particularly 
nce of Ieft ventricular dysfunction (1). In the case 
of valvular regurgitation, Doppler echocardiography is very 
sensitive in identifying regurgitant jets but may not reliably 
se te moderate from severe regurgitation. 
tant jets are frequently found in normal 
ut auscultatory evidence of valvular abnor- 
mality. With pulsed Doppler echocardiography. tricuspid re- 
urgitation has been reported in 24% to %% of normal 
subjects, mitral regurgitation in 10% to 4Q%, pulmonic regur- 
gitation in 18% to 92% and aortic regurgitation in 0% to 33% 
(2-S). In athletes, the occurrence of Doppler valvular regurgi- 
tation may be even higher, with at least one regurgitant jet 
found in >90% of the subjects and triple-valve regurgitation in 
20% (6). Most often these jets represent a trivial regurgitant 
volume and are of no clinical significance. 
Only rarely are cardiac catheterization and angiography 
n-q to classify valvular lesions hemodynamically. When 
symptomatic history may be unreliable (e.g., where secondary 
gain in denying symptoms is likely), then exercise tolerance 
testing and cardiac catheterization may be useful in this regard. 
Although there is considerable information concerning the 
determinants of sudden death and development of symptoms 
with exercise in patients with valvular heart disease, there 
are few data with regard to the rate of progression or severity 
of the valvular disease or factors that influence the rate of 
progression. Also, little is known about the influence of 
strenuoul; exertion on the progression of ventricular dysfunc- 
tion, especially when that exertion is periodic in nature. When 
valvular disease coexists with another cardiovascular abnor- 
mality, such as arrhythmias or coronary artery disease, recom- 
mendations with regard to eligibility for sports should be based 
on the most restrictive of these guidelines. 
We would like to emphasize that the present recommenda- 
tions with regard to the permitted level of athletic activity are 
offered only as guidelines. Physicians with knowledge of an 
individual athlete, including the severity of the lesion and the 
physiologic and psychologic response to competition, may 
liberalize these recommendations in selected instances. 
Mitral Stenosis 
The etiology of mitral stenosis, for practical purposes, is 
usually rheumatic. Most patients with significant mitral steno- 
sis will be sufficiently symptomatic so that they will not wish to 
engage in competitive sports. Patients with mild to moderate 
mitral stenosis may be asymptomatic even with strenuous 
exercise. Mitral stenosis rarely causes sudden death. The 
pathophysiology of the lesion results in increases in left atrial 
and pulmonary capillary pressure, leading to pulmonary hyper- 
tension, which is at times severe and which may ultimately 
result in right ventricular failure. Exercise, with an increase in 
heart rate and cardiac output, can cause sudden marked 
increases in pulmonary capillary and pulmonary artery pres- 
sures, at times resulting in sudden acute pulmonary edema (7). 
Another problem that may not be influenced by strenuous 
exercise associated with mitral stenosis is systemic emboliza- 
tion, occurring more commonly in the presence of atrisl 
fibrillation. The long-term effect of repeated exertion-related 
increases in pulmonary artery wedge and pulmonary artery 
pressures on the lungs or right ventricle is unknown. This must 
be understood by the patient and the family in considering 
participation in strenuous competitive activity. 
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of mitral stenosis by assessing the diastolic 
e area by Doppler echocardiography and 
iably by visualizing the mitral valve orifice 
(S). Although symptom limitation may be a problem, people 
who wish to engage in competitive sports may deny symptoms, 
causing the history to be unreliable. For this reason, a stress 
test performed to at least Ihe level of activity approximating 
the exercise demands of the competitive sport can be quite 
helpful in assessing exercise capacity, especially in patients with 
ecause left atrial pressure and pulmonary capillary pressure 
are directly related to the square of the cardiac output and 
inversely related to the square of rhc diastolic filling period, in fhc 
presence of mitral stenosis there is a marked increase in left atria1 
and pulmou;uy capillary lxcssure during any exercise that in- 
~rea~cs cardiac output SKI hc~t rate. Thcrcti~~, the rcsp~nr;c to 
exercise can be wry helpful in ~~etcr~li~iii~g the possible dillkill 
significance of any degree of mitral stenosis in an individual 
patient. Pulmonary artery systolic pressure during exercise can be 
estimated noninvasively by Doppler echocardiographic assess- 
ment of the peak velocity of rhe tricuspid regurgitant jet and may 
be helpful in making a decision as to how much activity is safe, 
even if the mitral stenosis in an individual patient is estimated to 
be only mild (9). If this is not practical or possible, then cardiac 
catheterization with exercise to measure the pulmonary capillary 
wedge pressure and pulmonary artery pressure should be per- 
formed in those patients with mitral stenosis and minimal or no 
symptoms who wish to engage in competitive sports, particularly 
when there is a question as to the severity of the mitral stenosis. 
In estimating the severity of mitral stenosis, associated mitral 
regurgitation should be taken into account in evaluating the 
calculated mitral valve area. 
Hemodynamic severity of the mitral stenosis can be cate- 
gorized as follows: rniki = mitral valve area >I..5 cm2 or 
exercise pulmonary artery wedge pressure 120 mm Hg or 
pulmonary artery systolic pressure ~35 mm Hg; ~no&tut~ = 
mitral valve area I.1 to 1.4 cm’ or exercise pulmonary artery 
wedge pressure ~25 mm Hg or rest pulmonary artery systolic 
pressure %Yl mm Hg; wxw = mitral valve area <I. I cm’ or 
exercise pulmonary artery wedge pressure >2!i mm Hg or rest 
pulmonav systolic pressure >50 mm Hg. Although the long- 
term effects of transient, severe elevations in pulmonary artery 
pressure are not yet known, athletes achieving a pulmonary 
artery systolic pressure X30 mm Hg during exercise should be 
considered as having severe hemodynamic consequences of the 
mitral stenosis, with potentially serious effects on the right 
ventricle as a result of the systemic pressure developed in the 
right ventricle. 
Effects of exercise. In patients with mitral stenosis, a mark- 
edly elevated heart rate or cardiac output for sustained periods 
of time could result in marked elevation of left atrial and 
pulmonary capillary pressure. Also, sustained elevation of 
systemic arterial ssure mighl increase left ventricular filling 
pressure and inc e !efF atria] pressure. Patients with mitral 
stenosis and atrial fibrillation must be receiving anticoaguja- 
tion (if there is no absolute CoaF~i~dicatio~) because of the 
high incidence of systemic emboli. Given these considerations, 
the following recommendations can be made. 
s rhythm with mild mitral stenosis can 
participate in all competitive sports. 
2. Athletes in atrial fibrillation with mild mitral stenosis, 
those in sinus rhythm or atrial fibrillation with modera!e 
stenosis and those with peak puhnon artery systolic pressure 
at rest or during exercise <SO mm can participate in low 
and moderate static and low and moderate dynamic competi- 
tive sports (classes IA, IR, liA and III3 lsee Table 1 in Class- 
ilication of Sporls]). 
3. Athlcles in atrial fibrillation or normal sinus rhythm with 
mild milral stenosis and a peak puhnonaly artery pressure of 
SO to X0 mm Hg can participate in low and moderate static and 
low dylralnic competitive sports only (classes IA and [IA). 
4. Athletes in either sinus rhythm or atria1 fibrillation with 
severe mitral stenosis or those with pulmonary artery pressure 
>XO mm Hg during exercise should not participate in any 
competitive sports. Those athletes taking anticoagulant agents 
should not engage in competitive sports that have a danger of 
bodily collision. 
itral Regurgitation 
Mitral regurgitation. unlike mitral shxwsis, has a variety of 
etiologies. The most common cause is mitral valve prolapse; 
other causes are rhUJmaric heart disease, infective endocdrdi- 
tis, coronary heart disease and other connective tissue diseases, 
such as h’hrhli’s syndrome and dilated cardiomyopathy. The 
recommendations outlined in this section are for those patients 
with primary valvular mitral regurgitation rather than mitral 
regurgiiation sccondaly to coronary disease or diseases causing 
left ventricular dilation. 
Evaluation. Mitral regurgitation can be detected by the 
characteristic physical findings. The severity of the mitral 
regurgitation is related to the magnitude of the regurgitant 
volume, which results in increased diastolic filling of fhe left 
ventricle and increased left atrial pressure. Increased diastolic 
left ventricular volume enhances left ventricular stroke volume 
enough to accommodate the regurgitant volume and to main- 
tain the forward stroke volume within normal limits. The low 
impedance presemed by regurgitation into the left atrium 
unloads the left ventricle during ventricular systole and al!ows 
for apparently good indexes of left ventricular global function 
despite true decreases in intrinsic contractility of the left 
ventricular myocardium (IO,1 I). 
The severity of chronic mitral regurgitation can bc ade- 
quately judged by noninvasive techniques, such as history of 
symptoms, physical examination, heart size on chest radio- 
graph, an ECG and Doppler echocardiography. Echocardiog- 
raphy is sensitive in detecting mitral regurgitation, hut the 
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severity of mitral regurgitation may be more difficult to esti- 
mate (12). Various signs of severe mitrLl1 regurgitation have 
&en described. If the regurgitant jet area is 4 to 8 Cd, mitral 
regurgitation is moderate; if >8 cm’, it is severe. The larger the 
width of the jet at its origin above the valve, the more severe 
the regurgitation. The entry of the jet into the atrial appendage 
or pulmonary vein or systolic reversal of the flow in pulmonary 
veins are all indicators of severity (13). In some patients with 
eccent* jets or those impinging on the atrial wall, the asseswnent 
may be ditlicult (14,15). Generally, in chronic mitral regurgitation, 
ti.g lefi ventricular diaslolie volume rekcts the severity of the 
mitral regurgitation. The problems faced by patients with mitral 
rcgurgitaticm arc I) inability to increase effective foward cardiac 
output appropriately; 2) increilw: in left atrial and pulmonary 
c@llary prepares, decreased left ventricular myocardial cmWx- 
liliv and left heart failure; and 3) right-&d heart failure. 
Embolization is ILXS common than with mitral stenosis and is 
pcoI,~,$ not influenced by competitive activity. Atrial IihrillatioiI 
occurs in association with enlargement of the left atriunr. 
Echoeardiography and radionuclide angiography can be used 
to evaluate left ventricular fun&n serially in ysh patients. A 
demase in ejection fraction or increase in end-systolic or end- 
diastolic volume probably indicates a dtvca.. in left ventricular 
contractility. The etiology of mitral regurgitation may be impor- 
tant in making recommendations concerning heavy ph$cal ac- 
tivity. For instance, mitral regurgitation related to coronary heart 
discasc has a ILYS favorable prognosis than primary forms of 
mitral regurgitation. and in such instances eligibiiiiy for czlmpet- 
itivc athktics should be based on the underlying coronary heart 
disease (see Tak Force 5). Patients with mitral rcgurgitatlon 
seamdaly to previous infLtiive endocarditis might have weak. 
cned the tissue% of the vahW, which tk)rctically could he further 
damaged or tom hy marked sustained increase% in left ventricular 
systolic presurc. Patients with atrial fibrillation should be rccciv- 
ing long-term anticoagulation. 
EMS al exercise. The effect of exercise on patients with 
mitral regurgitation has been studied in a limited number of 
patients (16). In general, in these studies there was no signif- 
icant change or a mild decrease in the regurgitant fraction 
he~auss the forward regurgitant Iows increased to the same 
extent. There is usually no change or a small decrease in 
ej&on friction with exercise, although the ejection fraction 
response may he completely normal in young, ilsplplolll~liC 
SuhjwAS. static exercise that increases arterial pressure is likely 
to worsen the regurgitation and to elevate the left atrial 
prt!ure and is therefore probably deleterious (17). It is known 
that chronic. exccssivc, prolonged volume overload leads to a 
progressive decrease in myocardial contractility. The presence 
of intermittent rcpclitivr incrcaw in volume load may there- 
fore bc a delc:&us factor in the progression of the disease. 
&Verity of mitril regurgitation can he estimated by the 
eliect on left ventricular size and systolic function. Because the 
chest radiograph can he misleading -as to the size of the left 
ventricle. the patient should be followed longitudinally with 
whocardiography and Doppler echocardiography or radionu- 
cli* angiography, or both. It slmrld be noted tht tite upper 
Recommendations 
1. Athletes in sinus rhythm with normal left ventricular size 
and function can participate in all competitive sports. 
2. Athletes in sinus rhythm or atrial fibrillation with mild left 
ventricular enlargement i Ild normal left ventricular function ill 
rest can participate in low and modcrdtc static and low and 
moderate dynamic competitive sports (classes IA, IB. IIA and 
IIB); selected athletes can cngJgc in some low and moderate 
static and low, moderate and high dynamic competitive sports 
(cl;!sses IA, IB. lC, IIA, IIB and UC). When atrial tihrillation is 
present, exercise testing can he utilized to ensure that the vcn- 
tricular rate response to cxcrcisc will not he cxccssivo. 
3. Athlctcs with dclinitc left ventricular cnlargcmrnt or any 
degree of left ventricular dysfunction at rest should not par- 
ticipate in any competitive sports. Those patients receiving 
long-term anticoagulation should not engage in sports involv- 
ing bodily COntilCl. 
Axtic Stmosis 
Etiolup;y. The diagnosis of aortic stenosis is easily made hy 
physical exammation. There are three common ctiologics: 
I) rheumatic. 2) congenital, and 3) cakilic or degenerative. It 
is recognized that calcilic or degenerative stenosis is frcqucntly 
the rtsult of a congenital abnormality of the aortic valve, 
CSpCCiillly when calcific ilOrtiC stenosis occurs 40 years Of Zlgc. 
Evaluation. The severity of aortic stenosis can usually he 
judged noninvasivcly by history, physical examination. the 
ECG and Doppler echocardiography. Continuous wave Dopp 
kr echocardiography can reliably cstimale the severity of 
sortie stenosis, especially in the prcsencc of normal cardiac 
output, which is usually the case in those engaging in compet- 
itive sports. It is rarely necessary to perform cardiac cathctcr- 
ization to assess the severity of aortic stenosis (18). 
Symptoms of left ventricular failure, syncopc or angina 
pcctoris occur late in the course of aortic stenosis (IV), and the 
occurrence of sudden death increases with the onset of symp 
toms. When doubt persists with regard to the severity of aortic 
stenosis after Doppler study, or if a patient with mild to 
moderate aortic stenosis has symptoms, cardiac catheterization 
should be performed. Sudden death is rare Gth mild aortic 
stenosis. Although sudden death is more frequent in symptom- 
atic patients with hcmodynamically severe aortic stenosis, it 
may aIS occur in completely asymptomatic patients (19-21). 
Scvcrity of aortic stenosis (in the presence of normal 
cardiac output) measured by cardiac Cdtheterizdtion or esti- 
mated with continuous wave Doppler echocardiography can be 
categorized as follows with respect to the n~eun aortic valve 
pressure gradient: mild, 520 mm Hg; moderate, 3.1 to 
39 mm Hg; and setjcre, ~40 mm Hg. It should be noted that in 
contrast to the presen! discussion of the severity of acquired 
aortic valve stenosis that relies on mean aortic valve gradient, 
the section on ~~~~~~~~~~~~~~ aortic stenosis (XC Task Force I) 
assesses the severity of aortic stenosis with respect to the ~XJ& 
i~?st~l~~a~r~ol~~~ aortic valve pressure gradient. 
ecause the severity of aorlic stenosis is oft~ 
c ~eev~~luati[~~l is ncccssaty and should bc performed by a 
n with expertise in cardiology (22,23). Th 
of gradient and valve area may be made by 
cardiography but could require periodic cardiac catheterization. 
In patients with aortic valve ssenosis. a markedly elevated 
cardiac output or peripheral vascular resistance for sustained 
periods of time could result in a marked increase in Ieft 
ventricular systolic pressure. Given these precautions, tk 
f~~llowi~g reco~i~~cadatio~s CM kC mid. 
1. AthlCtCs with mild aortic stenosis call participate ilr a!1 
compctitivc sports. AtbEctcs with i1 history of syncopc, cvcn 
with mild aortic stenosis, should hc card’ully cvalua(cd by a 
cardiologist. The asscsslI;cn~ should include cva 
arrhythUlins with exercise. Syncnpc SlWUld hc rcgardcd xi ;I 
possible sponta~leo~lsly iIlWrtCtl SMkh dCiltl1 iblld ShOtlId IX 
thoroughly investigated (set Task Force h). 
2. Athletes with mild to moderate aortic stenosis can 
engage in a!! low intensity competitive sports (class IA); 
selected athletes may participate only in low and moderate 
static and low and moderate dynamic competitive sports 
(classes IA, 15, !!A and HE). Exercise tolerance testing to at 
ieast the level of activity achicvcd in compciition is rccom- 
mended to evaluate exercise capacity, the development of ST 
segment depression, blood pressure response and arrhythmias. 
Such testing can be valuable in making the decision to allow 
patients to engage in this lcvc! of competitive sports. 
3. Athletes with mild or modcratc aortic stenosis and 
supraventricular tachycardia or multiple or complex ventricu- 
lar arrhythmias at rest or with exercise should participate in 
low intensity competitive sports only (class IA). 
4. Patients with severe aortic stenosis or symptomatic pa- 
tients with moderate aortic stenosis should not engage in any 
competitive sports. 
Aortic Regwgitcltim 
Etiology. Aortic regurgitation has multiple etiologies. Any 
disease affecting the aortic valve or ring or proximal ascending 
aorta can result in aortic regurgitation. The common etiologies 
are 1) congenital bicuspid aortic valve; 2) rheumatic heart 
disease; 3) infective endocarditis; and 4) aortic root diseases, 
including Marfan syndrome, ascending aortic aneurysm, aortic 
dissection, systemic hypertension and rheumatoid spondylitis. 
Evaluation. Aortic regurgitation increases left ventricular 
diastolic volume and stroke volume, which ultimately leads to 
congestive failure. There is also an increase in requirement for 
coronary blood rlow to the point of frequently exceeding the 
coronary supply. With exercise, there is a decrease in diastolic 
filling period and an increase in heart rate together with a 
decrease in peripheral vascular resistance; thus, forward flow is 
increased, and regurgitant volume is decreased (24). With 
severe aorlic regurgitation, angina ectoris, syncope, vent&- 
lar arrhythmias and sudden death can occur. 
The !lC~lOd~lla~llk SeVerity of aortic regurgitation call be 
assessed noninvasively by history and physical examination, the 
severity heiag reflected !~y the degree of left ventricular 
dilation and the peripheral signs of aortic regurgitation. Left 
ventricular dilation can be judged grossly by chest radiograph 
but more precisely by echocardiography. It must be noted that 
the upper limit of norma! left ventricular size is increased in 
the healthy, highly trained athlete, and this may well affect 
assessment of left ventricular enlargement in the setting of 
aortic regurgitation. Because of the importance of assessing left 
VCWiCulilr function atld the size of the ilOl$c root and piaximz] 
ascending aorta in dctcrmining the etiology with resulting impli- 
cations i;Jr atbk !ic participation, evaluation by cchocardiography 
is lWO~ll~llclldcd. i)o!dcr cchoc;irdicgrapliy is very sensitive in 
Jctccting any dcgrec of aortic regurgitation. Similar to mitral 
regurgitalion, the grcatcst difticulty arises in diffcrcntiating mod- 
CriltC d scvcrc aorlic rcgurgitalion. In gcmml, I!lc w&h of the 
regurgitant jet and the proportion of the left ventricular outflow 
tract occupied by the jet arc related to the severity of the aortic 
regurgitation. 41~0, the slope of the decrease in velocity of the 
profile of the diastolic jet is determined by the decrease in 
diastolic gradient and therefore also reflects the severity of the 
regurgitation (25). Exercise testing can be useful in assessing 
cxcrcisc capacity, especially in those patients having nonspecific 
or mild symptoms. 
Left ventricular function can bc asscsscd and followed up 
serially by hvo-dimensional echocardiography and radionuclide 
angiography. In such patients, the significance of a decrease in 
ejection fraction with exercise is unclear. This probably represent.: 
an increase in left ventricular wall stress, but not enough is 
currently known about this finding to USC it to formulate a 
recommendation as to the advisability of engaging in competitive 
athletics (26). There are no data to define whether severe 
increases in physical activity permanently affect the function of 
the left ventricle. Because of the possibility of progression in the 
severity of aortic regurgitation, annual evaluation is recom- 
mended. 
The hemodynamic severity of aortic regurgitation can be 
classified with respect to its periphcra! signs and the effect of the 
volume overload on left ventricular function (as assessed by 
Doppler echocardiography). Because chest radiography can be 
misleading as to left ventricular volume and aortic root size, 
combined echocardiography and radionuclide angiography are 
recommended in the serial assessment of left ventricular size and 
function, Exercise testing is recommended to at least the level of 
exertion required by the proposed competitive sport. In this way, 
the patient’s tolerance of this degree of exercise can be evaluated. 
Ijemodynamic severity of aortic regurgitation can be 
graded as follows: mild = absent to slight peripheral signs of 
aortic regurgitation, normal left ventricular size; mod~~~~~~ = 
peripheral signs of aortic regurgitation with mild to moderate 
increases in left ventricular size with normal systolic function; and 
severe = peripheral signs of aortic regurgitation with severe left 
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ventricuku enlargement or any degree ofleft ventricular eniarge- 
ment if left ventricular dysfunction s present. 
Reeommendotions 
1. Athletes with mild or moderate aortic regurgitation, but
with left ventricular size that is normal or only mildly increased 
above that which would be expected to result solely from 
athletic training (see arlier), can participate in a!! competitive 
sports. In selected instances with moderate l ft ventricular 
enlargement, athletes can engage inlow and moderate static 
and low, moderate and high dynamic competitive sports (ciass- 
es IA, IB, IC, IIA, IIB and UC). Those with evidence of
progressive l ft ventricular enlargement on serial studies 
should not engage incompetitive sports, 
2. Athletes with mild or moderate aottic regurgitation and 
ventricular rhythmias t rest or with excttion should partic- 
ipate in low intensity competitive sports only (class IA) (see 
also Task Force 6). 
3. Athletes with severe aortic regurgitation as we!! as those 
with mild or moderate r gurgitation and symptoms (regardless of 
left ventricular dimension) should not participate in any compet- 
itive spot& 
4. Those with aortic regurgitation a d marked ilation of 
the proximal scending aorta should not engage in any com- 
petitive sports. 
5. In athletes with Marfan’s syndrome and aottic regurgi- 
tation, the previous criteria for aortic valve disease apply. In 
addition to aortic regurgitation, Marfan’s syndrome presents 
other clinical problems, including those related to aortic 
dissection a d rupture, which arc discussed in Task Force 1. 
Tricuspid Regurgira ti n 
Tricuspid regurgitation is most often secondary to tight 
ventricular dilation and failure due to pulmonary or right 
ventricular hypertension. Rheumatic heart disease and infec- 
tive endocarditis are less common causes. Recommendations 
here with respect to athletes are for those with primary 
tricuspid regurgitation. 
Primaty tricuspid valvular regurgitation leads to volume ovet- 
load of the right ventricle with increased systemic venous pressure 
and its consequences. There is no evidence that he athlete with 
isolated primary tricuspid valvuiar regurgitation is placed in 
jeopardy by engaging in heavy physical exertion. The long-term 
effects ofchronic volume overload on right ventricular function 
are unknown but are probabIy deleterious. Severity oftricuspid 
‘tation can he estimated noninvasively from physical exam- 
ination, chest radiiph and Doppler echocardiography. 
Recommendatiaa. Athletes with primary tricuspid vaivuiar 
regurgitation, regardless of severity, in the absence of right 
atrial pressure >20 mm Hg and in the absence ofelevation of
right ventricular systolic pressure with normal right ventricular 
function can engage inal! competitive sports. 
Tricuspid Stenosis 
Tricuspid stenosis i  for the most part caused by rheumatic 
heart disease and is nearly always associated with mitral 
stenosis. Inthat instance, the patient should be judged accord- 
ing to the severity of the mitral stenosis. Isolated tricuspid 
stenosis rare. Such patients should undergo exercise t sting 
at least o the level anticipated in their sport. If asymptomatic, 
athletes may compete ina!! competitive sports. 
Multivalvular Disease 
~uitivaiv~~ar disease occurs in the context of r 
heart disease, myxomatous valvuiar disease and infect 
carditis. With left ventricular failure and the consequent left 
atria! and pulmonary arterial hypertension, mitral and tricus- 
pid re~~~t~i~tio~ can ccur. 
The lesions can be diagnosed by physical examination with 
and without the aid of Doppicr echocardiography. T e relative 
contribution ofeach of the lesions may be difdicuit to assess 
noninvasiveiy, and cardiac atheterization and angiocardio- 
graphy are frequently necessary to resolve these distinctions. 
ecommendatior. In genera!, thletes with significant muiti- 
pie vahuiar disease should not participate in any competitive 
sports. Recommendations should bc based on the most hemody- 
namicaily severe l sion. However, it is recognized that rnu~ti~~e 
lesions of moderate s verity may have additive physiologic effects. 
Postoperative Patients With a Prosthetic or 
~i~p~st~letic cardiac Valve 
There are several genera! comments hat apply to a!! 
patients with valve replacement. First, although most patients 
improve after valve replacement, and many become asymp 
tomatic, the long-term ortality after operation is greater than 
that which could be expected in a genera! population ofsimilar 
age. Second, a ttansvaivuiat gradient of varying severity is
present in most patients after valve replacement (27). Third, 
although emodynamic variables at test may be essentially 
normal after valve replacement, many patients have an abnot- 
ma! response toexercise (28). However, vigorous exercise does 
not appear to produce hemoiysis in patients with normally 
functioning prosthetic valves. Inassessing the athlete’s capacity 
for physical ctivity, exercise stress testing to at least he level 
of activity performed in the competitive sport is valuable. 
Finally, after valve replacement (with few exceptions) patients 
with prosthetic valves require anticoagulant gents, and those 
with bioprosrhetic vahes usually do not. 
Effects of exercise. There are insufficient data to determine 
whether vigorous repetitive exercise after valve replacement 
has any long-lasting effect on ventricular o prosthetic valve 
function (29). The patient should be made aware of these 
deficiencies in out knowledge before deciding whether to 
participate in competitive athletics. 
Because prosthetic and most tissue valves have reduced 
effective alve areas, and prosthetic valve poppets have greater 
inertia than normal, these valves perform best at normal heart 
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rates. erefore, a sustaine heart rate >120 to 130 beats/ 
minute m~gbt result in that are less 
than normally expect higher than 
would be expected. S etic midraP 
is best evsrlgated wit 
eco 
1. Athletes with a prosthetic or biopros etic r&al vaive not 
taking anticoagulant agents who have nor I valvular function 
2nd rnrd nr x:w~ ntrrmal left ventricular ~~~ct~ol~ can partici- 
pate in low and moderate static 
competitive sports (classes IA, I 
ent of other considerations, athletes with a 
prosthetic mirml or uortic wlw who are taking 
age in sports with a danger 
of bodily collision. 
3. Athletes with a prosthetic or bioprosthctic r&c r&e not 
taking anticoagulant agents, without valvular dysfunction and 
with normal or near-normal left vsntricular function can cngagc 
in low intensity competitive sports (class IA) 
participaie in low and moderate static an 
dynamic competitive sports (classes IA, IS, IIA and 11B). 
There are certain general comments that apply to valvulo- 
plasty in this context. Valvuloplasty is possible in many patients 
with mitral regurgitation, especially those with rupture of the 
chordae tendineae of the posterior leaflet or prolapse of the 
posterior leaflet. There is increasing expertise in repairing 
mitral valves with mitral regurgitation as an alternative to 
surgical replacement. Although the benefits of repair of the 
valve appear to persist long term, the ultimate fate of repaired 
valves has yet to be determined. In patients with mitral stenosis 
and ffexible leaflets with no or minimal mitral regurgitation, 
balloon valvuloplasty appears to bc similar in risk and results to 
mitral commissurotomy (31). After recovery from either closed 
or open mitral valvuloplasty or balloon valvuloplasty, the 
patient should have no disability associated with the operation 
if there has been no injury to the left ventricle or increase in 
mitral regurgitation. Aortic valvuloplasty is not uncommonly 
performed in young patients with aortic valve stenosis. Subse- 
quent o this procedure, problems may arise with respect to 
endocarditis or calcification of the aortic valve requiring 
operation. Athletes should be evaluated for competitive sports 
on the basis of their esidual hemodynamic state. 
Recommendations 
I. For postoperative patients with mitral stenosis (or occa- 
sionally with mitral regurgitation), recommendations withre- 
gard to participation in competitive sports hould be based on 
the residual severity ofthe mitral stenosis or mitral regurgita- 
tion, as in the patient without operation. Capacity oengage in
physical exercise should be evaluated with an exercise toler- 
ance test at least to the level of anticipated activity. If left 
ventricular dysfunction is present, then this should be consid- 
ered in the same context as in the patient without operation. 
2. Athletes with ann~loplas~ or valvulop~asty wi hmitral 
cause of the possibility of tr 
not engage insports with a 
collision. They can partjc~~ate in low intensity competitive 
sports (class IA) and, in selected athletes, in low and moderate 
static and low and moderate dynamic ompetitive sports 
(classes IA, IB, HA and IIB). 
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Hypertrophic Ca~i~~yQ 
Geneml Considerations 
Hypertrophic cardiomyopathy, although a relatively un- 
common cardiac malformation (-0.1% to 0.2% of the general 
population) (I), is of great importance bccausc it is probably 
the most common cause of uncxpccted sudden cardiac death in 
young people, including competitive athletes (2-12). Indeed, 
sudden death in hypertrophic cardiomyopathy usually occurs 
in the absence of previous symptoms (2-7,10-12). 
Hypertrophic cardiomyopathy is a primary cardiac disease 
in which the most consistent diagnostic feature demonstrated 
by echocardiography is an asymmetrically hypertrophied and 
nondilated left ventricle in the absence of another cardiac or 
systemic disease associated with left ventricular hypertrophy 
(13). The clinical and morphologic expression and natural 
history is recognized to be particularly diverse and hetero- 
geneous (14-21). The familial form of the disease (22) is 
genetically heterogeneous and has been attributed to several 
genetic defects invoking contractile proteins trcponin T and 
alpha-trcpomyosin and a number of missense mutations of the 
beta-myosin heavy-chain gene (23-26). 
Hypertrophic cardiomyopathy is generally regarded to be 
present when the maximal diastolic left ventricular wall thickness, 
as defined by echocardiography, is 215 mm in an adult (or the 
equivalent, relative to body surface area, in children). However, it 
is also recognized that some a&ted patients with hypertrophic 
caLrdiowpathy have wall thicknesses Cl5 mm (21,22), whereas 
a subgroup of highly trained male athletes without cardiovascular 
disease (i.e., athlete’s heart with physiologic hypertrophy) may 
show wall thicknesses that exceed normal limits (i.e., >l2 mm, 
ranging up to I6 mm) (27). Therefore, left ventricular wall 
thicknesses of I3 to 14 mm may place an individual athlete in an 
inconclusive diagnostic “gray zone” (28). Such a circumstance 
may not easily permit a definitive distinction of hypertrophic 
cardiomyopathy from the physiologic “athlete’s heart,” in which 
left ventricular hypertrcphy is not truly pathologic (28). In such 
instances, additional data, including identification of other echo- 
cardiographic or clinical features most consistent with either 
hypertrophic cardiomyopathy or “athlete’s heart” (29,30), should 
be sought to resolve this sometimes difficult differential diagnosis. 
It should be emphasized thiit there is also considerable risk 
to the well-being of the athlete associated with the cverdiag- 
ncsis of hypertrophic cardiomyopathy in borderline cases 
because this diagnosis may be based solely on the echocardic- 
graphic assessment of left ventricular wall thickness and often 
in only a single segment of the ventricle. Therefore, the reccm- 
mendations of this Task I&c are predicated on the presumption 
that the clinical diagnosis of hypertrcphic cardiomyopathy in a 
given athlete has been judged to be highly probable or definite. 
In hypertrcphic cardiomyopathy, the pattern and extent of left 
ventricular hypertrophy is diverse, but a greater magnitude and 
extent of wall thickening appear to convey less favorable clinical 
consequences (9,31,32). We also recognize that the phenctypic 
expression of hypertrophic cardiomyopathy (i.e., unexplained left 
ventricular wall thickening) may be incompletely expressed in 
young patients who are in the age range of many competitive 
athletes (i.e., ~18 years old), and in some instances full morpho- 
logic manifestation of the disease may not be clearly evident until 
young adulthood (33). 
